{"transactions":[{"id":3959181,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-19","kind":"exercise","acquired":false,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable in four equal installments beginning on February 24, 2018, which was the first anniversary of the date on which the option was granted."}],"balance_after":38400,"derivative":{"exercise_price":25.3,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":7850},"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959180,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-18","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable in four equal installments beginning on February 24, 2018, which was the first anniversary of the date on which the option was granted."}],"balance_after":46250,"derivative":{"exercise_price":25.3,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959179,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-18","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in four equal installments beginning on March 1, 2017, which was the first anniversary of the date on which the option was granted."}],"balance_after":25000,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959178,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-19","kind":"sale","acquired":false,"shares":7850,"price":49.0261,"value":384854.885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.15, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959177,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-19","kind":"exercise","acquired":true,"shares":7850,"price":25.3,"value":198605.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."}],"balance_after":17194,"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959176,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":10000,"price":47.0617,"value":470617.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.25, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959175,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":3750,"price":25.3,"value":94875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."}],"balance_after":19344,"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3959174,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-04-20T20:53:07.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":6250,"price":12.98,"value":81125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."}],"balance_after":15594,"source":{"system":"sec-edgar","filing":"0001104659-18-025639","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918025639/a4.xml","form_type":"4"}},{"id":3966861,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable in four equal installments beginning on March 1, 2017, which was the first anniversary of the date on which the option was granted."}],"balance_after":31250,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966860,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"exercise","acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in four equal installments beginning on March 3, 2016, which was the first anniversary of the date on which the option was granted."}],"balance_after":8750,"derivative":{"exercise_price":9.13,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966859,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal installments beginning on January 21, 2015, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":9.24,"expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966858,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"sale","acquired":false,"shares":18750,"price":45.3295,"value":849928.125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.1500 to $45.9750, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966857,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"exercise","acquired":true,"shares":18750,"price":12.98,"value":243375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."}],"balance_after":28094,"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966856,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"sale","acquired":false,"shares":26250,"price":45.3295,"value":1189899.375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.1500 to $45.9750, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966855,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"exercise","acquired":true,"shares":26250,"price":9.13,"value":239662.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."}],"balance_after":35594,"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966854,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"sale","acquired":false,"shares":15000,"price":45.3295,"value":679942.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.1500 to $45.9750, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":3966853,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-04-09T16:12:20.000Z","date":"2018-04-05","kind":"exercise","acquired":true,"shares":15000,"price":9.24,"value":138600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 6, 2018."}],"balance_after":24344,"source":{"system":"sec-edgar","filing":"0001104659-18-023012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918023012/a4.xml","form_type":"4"}},{"id":4051360,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T21:58:26.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 14, 2019."}],"balance_after":33000,"derivative":{"exercise_price":39.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-18-010412","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918010412/a4.xml","form_type":"4"}},{"id":4097584,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-17T23:44:02.000Z","date":"2018-01-17","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in four equal installments beginning on January 21, 2015, which was the first anniversary of the date on which the option was granted."}],"balance_after":15000,"derivative":{"exercise_price":9.24,"expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-18-002701","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002701/a4.xml","form_type":"4"}},{"id":4097583,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-17T23:44:02.000Z","date":"2018-01-17","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001104659-18-002701","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002701/a4.xml","form_type":"4"}},{"id":4097582,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-17T23:44:02.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":15000,"price":47.0333,"value":705499.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.10, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-002701","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002701/a4.xml","form_type":"4"}},{"id":4097581,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-17T23:44:02.000Z","date":"2018-01-17","kind":"exercise","acquired":true,"shares":15000,"price":9.24,"value":138600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."}],"balance_after":24344,"source":{"system":"sec-edgar","filing":"0001104659-18-002701","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002701/a4.xml","form_type":"4"}},{"id":4097580,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-17T23:44:02.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":9250,"price":45,"value":416250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-002701","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002701/a4.xml","form_type":"4"}},{"id":4097579,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-17T23:44:02.000Z","date":"2018-01-17","kind":"exercise","acquired":true,"shares":9250,"price":7.9,"value":73075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."}],"balance_after":18594,"source":{"system":"sec-edgar","filing":"0001104659-18-002701","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002701/a4.xml","form_type":"4"}},{"id":4099162,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-16T21:49:20.000Z","date":"2018-01-12","kind":"exercise","acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":9250,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001104659-18-002401","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002401/a4.xml","form_type":"4"}},{"id":4099161,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-16T21:49:20.000Z","date":"2018-01-12","kind":"sale","acquired":false,"shares":5750,"price":45.0309,"value":258927.675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.45, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-002401","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002401/a4.xml","form_type":"4"}},{"id":4099160,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-16T21:49:20.000Z","date":"2018-01-12","kind":"exercise","acquired":true,"shares":5750,"price":7.9,"value":45425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."}],"balance_after":15094,"source":{"system":"sec-edgar","filing":"0001104659-18-002401","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918002401/a4.xml","form_type":"4"}},{"id":4102781,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-10T00:37:21.000Z","date":"2018-01-09","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":15000,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-18-001524","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918001524/a4.xml","form_type":"4"}},{"id":4102780,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-10T00:37:21.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":15000,"price":42.0433,"value":630649.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.0000 to $42.4000, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-001524","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918001524/a4.xml","form_type":"4"}},{"id":4102779,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-10T00:37:21.000Z","date":"2018-01-09","kind":"exercise","acquired":true,"shares":15000,"price":7.9,"value":118500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."}],"balance_after":24344,"source":{"system":"sec-edgar","filing":"0001104659-18-001524","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918001524/a4.xml","form_type":"4"}},{"id":4106890,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-04T21:07:08.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":30000,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001104659-18-000771","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918000771/a4.xml","form_type":"4"}},{"id":4106889,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-04T21:07:08.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":55000,"price":40.1147,"value":2206308.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0000 to $40.7000, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001104659-18-000771","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918000771/a4.xml","form_type":"4"}},{"id":4106888,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Common Stock","published_at":"2018-01-04T21:07:08.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":55000,"price":7.9,"value":434500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted November 21, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 785 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4."}],"balance_after":64344,"source":{"system":"sec-edgar","filing":"0001104659-18-000771","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918000771/a4.xml","form_type":"4"}},{"id":4420857,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":167380,"kind":"person","name":"Vaughn Victor","position":1,"cik":"0001567077","reported_name":"Vaughn Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Sales"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-28T02:58:50.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal installments beginning on February 24, 2018."}],"balance_after":50000,"derivative":{"exercise_price":25.3,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-17-012177","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465917012177/a4.xml","form_type":"4"}}]}